Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (341-350 of 542) with videos related to

Pageof 55
Sort By:
Infection Control and Hospital Epidemiology|June 5, 1998
Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive-care unitS L Fowler, B Rhoton, S C Springer, et al.
Diagnostic Microbiology and Infectious Disease|February 4, 2018
Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015)M A Pfaller, R K Flamm, L R Duncan, et al.
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1992
Developments in the diagnostic mycology laboratoryG D Roberts, M A Pfaller, E Gueho, et al.
Infection Control and Hospital Epidemiology|March 4, 1999
Investigation of suspected nosocomial clusters of Staphylococcus haemolyticus infectionsT M Perl, W A Krüger, A Houston, et al.
Journal of Clinical Microbiology|October 17, 1998
Comparison of genomic methods for differentiating strains of Enterococcus faecium: assessment using clinical epidemiologic dataC Savor, M A Pfaller, J A Kruszynski, et al.
Journal of Clinical Microbiology|October 2, 2009
Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogensM A Pfaller, S A Messer, N Georgopapadakou, et al.
Journal of Clinical Microbiology|January 4, 2001
Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureusT Yamazumi, S A Marshall, W W Wilke, et al.
Diagnostic Microbiology and Infectious Disease|February 20, 2004
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agentsM A Pfaller, D J Diekema, S A Messer, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strainsR N Jones, M A Pfaller, P C Fuchs, et al.
Journal of Clinical Microbiology|March 26, 2010
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida speciesM A Pfaller, M Castanheira, D J Diekema, et al.
Pageof 55

Showing results (341-350 of 542) with videos related to

Sort By:
Pageof 55
Infection Control and Hospital Epidemiology|June 5, 1998
Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive-care unitS L Fowler, B Rhoton, S C Springer, et al.
Diagnostic Microbiology and Infectious Disease|February 4, 2018
Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015)M A Pfaller, R K Flamm, L R Duncan, et al.
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1992
Developments in the diagnostic mycology laboratoryG D Roberts, M A Pfaller, E Gueho, et al.
Infection Control and Hospital Epidemiology|March 4, 1999
Investigation of suspected nosocomial clusters of Staphylococcus haemolyticus infectionsT M Perl, W A Krüger, A Houston, et al.
Journal of Clinical Microbiology|October 17, 1998
Comparison of genomic methods for differentiating strains of Enterococcus faecium: assessment using clinical epidemiologic dataC Savor, M A Pfaller, J A Kruszynski, et al.
Journal of Clinical Microbiology|October 2, 2009
Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogensM A Pfaller, S A Messer, N Georgopapadakou, et al.
Journal of Clinical Microbiology|January 4, 2001
Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureusT Yamazumi, S A Marshall, W W Wilke, et al.
Diagnostic Microbiology and Infectious Disease|February 20, 2004
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agentsM A Pfaller, D J Diekema, S A Messer, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strainsR N Jones, M A Pfaller, P C Fuchs, et al.
Journal of Clinical Microbiology|March 26, 2010
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida speciesM A Pfaller, M Castanheira, D J Diekema, et al.
Pageof 55